drugset / Trial / NCT05053321
Reduction of Demoralization in Patients With Tardive Dyskinesia After Treatment With Valbenazine
NaSingle-groupOpen-labelTreatment
Summary
This will be an Investigator-initiated pilot study in which participants will be assessed with various scales to measure demoralization, anxiety, depression, and subjective incompetence at baseline and every two weeks after treatment with Valbenazine for a total of 6 weeks. Improvement in TD will be assessed as well and correlated with reduction in demoralization.
Timeline
- Start
- 2024-10-18
- Primary completion
- 2025-10-18
- Completion
- 2025-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valbenazine | Small molecule | — | — |